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guarantee against secondary disruption or
leakage. Except for the discomfort experi-
enced by the patients, the cumulative risk
for the multiple-stage approach can reason-
ably be presumed to be higher than that
reported by Dr Kouchoukos et al and our-
selves for the single-stage approach. For
these reasons I strongly recommend Dr
Kouchoukos and colleagues’ suggestions
to trust the single-stage techniques in se-
lected cases whenever indicated.
Carmine Minale, MD
Cardiovascular Department
Division of Cardiovascular Surgery
Ospedale San Carlo
Potenza, Italy
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Reply to the Editor:
My coauthors and I are indebted to Dr
Minale and colleagues for reporting their
initial experience with the single-stage
technique for extensive thoracic aortic re-
sections in 1994,1 which stimulated us to
use and evaluate it in our surgical practice.
We also appreciate the update of their ex-
perience with this technique, which indi-
cates outcomes very similar to those that
we have reported.2 We prefer, however, to
cool to systemic temperatures lower than
25°C to provide additional protection in the
event that the ischemic intervals for the
brain and spinal cord are prolonged beyond
the usual safe intervals. We do not believe
that the lower temperatures are associated
with increased morbidity. We have found
that an incision through the fourth intercos-
tal space bilaterally provides excellent ex-
posure of the aortic root, entire aortic arch,
interatrial groove, and most distal portion
of the descending thoracic aorta.
We agree with Dr Minale that the sin-
gle-stage technique is of particular value in
patients who require reoperation after pre-
vious repair of an acute type A aortic dis-
section or who have a type A dissection
after previous coronary artery or valve sur-
gery. Chronic type A dissection was the
indication for use of the single-stage pro-
cedure in 30 of the 46 patients in our series,
and the procedure remains our technique of
choice in this setting.2 It permits, as Dr
Minale has emphasized, easy access to
both the aortic root and the distal descend-
ing thoracic aorta.
Nicholas T. Kouchoukos, MD
Cardiac, Thoracic and Vascular Surgery Inc
St Louis, MO 63131
References
1. Minale C, Splittgerber FH, Wendt G, Mess-
mer BJ. One-stage intrathoracic repair of ex-
tended aortic aneurysms. J Card Surg. 1994;
9:604-13.
2. Kouchoukos NT, Mauney MC, Massetti P,
Castner CF. Single-stage repair of extensive
thoracic aortic aneurysms: experience with
the arch-first technique and bilateral anterior
thoracotomy. J Thorac Cardiovasc Surg.
2004;128:669-76.
doi:10.1016/j.jtcvs.2005.01.002
Total aortic arch replacement and
limited circulatory arrest of the brain
To the Editor:
We read with great interest the article by
Kouchoukos and Masetti1 titled “Total
Aortic Arch Replacement With a Branched
Graft and Limited Circulatory Arrest of the
Brain,” published in the August 2004 issue
of the Journal. The article describes the
authors’ experience with total arch replace-
ment (TAR) for various pathologic condi-
tions of the aortic arch (except acute type A
dissection) with branched aortic prostheses
and unilateral antegrade cerebral perfusion
through the right axillary artery. The article
generally attests to the appropriateness of
the use of branched aortic prosthesis and
antegrade brain perfusion for TAR surgery.
Since 1986, we have been routinely using
antegrade selective cerebral perfusion and
a branched aortic graft for TAR proce-
dures.2 The results we have achieved
through the years give us reason to be
convinced that the use of the branched
grafts rather than tube prostheses and ante-
grade brain perfusion for cerebral protection
represent the optimum surgical strategy for
this complex surgery.3 The branched aortic
graft allows easier bleeding control at arch-
vessel anastomotic sites and has been
found to be associated with a lower inci-
dence of postoperative strokes, making it a
better option than tube graft. Similarly, se-
lective cerebral perfusion, when used to its
full potential, basically relieves the surgeon
from the psychologic burden of a limited
brain protection time and thus allows me-
ticulous arch repair. It is good to see that
more and more aortic surgeons all over the
world are realizing the advantages of these
techniques, which once were thought to be
cumbersome.
Concerns have been expressed by
some authorities, including Kouchoukos
and Masetti,1 regarding the potential haz-
ards of direct cannulation of the arch ves-
sels in the form of cerebral embolization of
air or debris. In our experience, such con-
cerns are mostly unwarranted. Our arch
vessel cannulation technique involves tran-
secting the arch vessels distant from their
origins, at sites where they are free from
atherosclerotic debris or dissection, and
then cannulating them under direct vision.
Blood flow through the arch vessels is con-
tinued until just before the cannulation with
the patient in a Trendelenburg position.
These measures help to avoid air embo-
lism.4
For patients with acute type A aortic
dissection and degenerative arch aneurysm
requiring TAR in whom the ascending
aorta is not suitable for arterial inflow be-
cause of atheromas, we first cannulate the
right axillary artery through an 8-mm graft
attached to it in an end-to-side fashion.
Then, after cooling of the patient with car-
diopulmonary bypass and initiation of cir-
culatory arrest, the left common carotid
artery is also cannulated, ensuring bihemi-
spheric antegrade brain perfusion during
the arch repair. Although some authors
have advocated the use of unilateral cere-
bral perfusion for aortic arch replacement
surgery,5 our experience with that tech-
nique is limited to cases requiring a less
radical aortic repair, such as ascending aor-
tic replacement with open distal anastomo-
sis or hemiarch replacement. In 10 patients
(acute type A dissection n  7, chronic
type A dissection n  1, degenerative arch
aneurysm n  1, and mycotic arch aneu-
rysm n  1), hemiarch replacement was
carried out with right axillary artery perfu-
sion as the only brain protection method
under moderate hypothermic circulatory
arrest (mean rectal and tympanic tempera-
tures 22.3°C  1.6°C and 16.9°C  2.4°C,
respectively). Mean perfusion flow rate and
pressure were 5.1  1.9 mL/(kg · min) and
27.8  9.4 mm Hg, respectively. Mean
selective cerebral perfusion time was 35.8
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 14.1 minutes. There was 1 postoperative
death from an unrelated cause, and no tem-
porary or permanent neurologic deficits
were seen. Although this represents a sat-
isfactory outcome, routine adoption of uni-
lateral brain perfusion for TAR, which usu-
ally requires a longer brain protection, may
not always be equally successful. If it has
to be done, however, a more substantial
lowering of core body temperature might
be helpful.
The arch-first strategy described by
Kouchoukos and Masetti1 may not al-
ways be advantageous. This is because it
makes the distal aortic anastomosis more
difficult, with the bulky aortic prosthesis
coming to obscure much of the operative
field. Moreover, deep hypothermia still
needs to be continued during the distal
anastomosis. As Kouchoukos and Ma-
setti1 say, a bilateral anterior thoracot-
omy will facilitate the distal anastomosis
in these situations.
Finally, we think that despite the small
number of patients studied, Kouchoukos
and Masetti1 deserve credit for the results
they obtained with unilateral brain perfu-
sion for TAR. However, preoperative as-
sessment of the cerebral circulation as well
as careful selection of cases should always
be considered before deciding on a brain
protection strategy.
Teruhisa Kazui, MD, PhD
Abul Hasan Muhammad Bashar, MBBS, PhD
Naoki Washiyama, MD, PhD
First Department of Surgery
Hamamatsu University School of Medicine
Hamamatsu, Japan
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Bioengineered airway tissue
To the Editor:
In the brief communication “First Human
Transplantation of a Bioengineered Air-
way Tissue,” Macchiarini and associates1
point out that tracheal replacement by
tissue engineering seems to hold poten-
tial. Question is to be raised whether this
report actually does provide “definitive
evidence that a tissue engineered patch-
. . . can functionally . . . fill all require-
ments for an airway patch.”
The patch was applied to a defect 1.5 
1.5 cm after breakdown of anastomosis af-
ter carinal pneumonectomy. Omentum was
applied over the patch; this was further
buttressed, and the space was filled with a
subscapular muscle flap. To further oblit-
erate the space, complementary thoraco-
plasty was performed. The leak healed, and
ciliated respiratory epithelium was eventu-
ally found to cover the repaired defect.
Closure of a defect such as this with an
omental flap, especially with further use of
a muscle flap plus thoracoplasty to obliter-
ate residual space, would in most cases
suffice to seal the defect successfully. Ep-
ithelium undoubtedly migrates from the re-
spiratory epithelium of the surrounding tra-
chea and bronchus to cover the scar that
forms over the mesenchymally repaired de-
fect. Epithelization occurs over vascular-
ized autogenous flaps used over smaller
defects in trachea and bronchi. Whether the
graft actually survived or the tissue ulti-
mately seen was partly or entirely scar that
would form over the mesenchymal bed of
omentum is not demonstrated.
One must also question placement of a
free graft of any tissue over an area that is
still contaminated, even if not grossly in-
fected, by the bacteria that necessarily are
present in such a situation, despite all
cleanup treatment before repair. More to
the point, however, is the fact that defects
of this sort have long been closed by vas-
cularized pedicled autogenous tissues
(omentum, pericardium, intercostal mus-
cle, and other muscle flaps). Addition of an
engineered tissue graft seems superfluous.
The potential of bioengineering to pro-
duce tracheal replacement segments in the
future is a goal worthy of continued re-
search attention nonetheless.
Hermes C. Grillo, MD
Division of General Thoracic Surgery
Massachusetts General Hospital
Boston, MA 02114
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Reply to the Editor:
It is a distinct privilege to have attracted the
interest of Hermes Grillo, and frankly
speaking, his comments were expected. In
his letter to the Editor, Dr Grillo questions
clinical and experimental issues that I am
delighted to address.
It is certainly correct that the airway
defect could have been closed without the
interposition of the engineered airway tis-
sue. However, we all know that (1) it is
technically demanding and risky to free (by
further devascularizing it) a leaky postra-
diation (70 Gy) carinal anastomosis, and
that (2) an intrathoracic transposed omen-
tum buttressed over an airway defect is
almost never immediately tight, and this
jeopardizes the spillage of omentum pro-
duced fluid into the unique lung and in-
duces a motion- (and foreign body-) tem-
porary cough.
However, and with great respect, we
disagree that the addition of an engineered
airway tissue was superfluous. From a clin-
ical viewpoint, a repeatedly thoracoto-
mized and previously irradiated (70 Gy)
operative field is unlikely to guarantee en-
grafting (eg, intercostals muscle) or allow
harvesting (pericardium) of autogenous tis-
sues. Hence, the closure of the defect with
the tissue-engineered graft ensured a tight
interface permitting a physiologic secretion
transport without having all the complica-
tions related to the indirect closure through
autogenous tissues. Having experienced
the scenario with and without1 this new
tool, I must admit my pleasure in having an
extremely powerful and valid clinical alter-
native.
From an experimental viewpoint, our
disagreement is even more important be-
cause the lessons learned from this clinical
application are very important. Because of
the concise nature of the chosen article
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